Cargando…

Efficacy of Neutrophil-to-Lymphocyte Ratio for Cancer-Specific Survival in Elderly Patients with Localized Colon Cancer: A Single Center Propensity Score-Matched Analysis

PURPOSE: The prognostic value of neutrophil-to-lymphocyte ratio (NLR) has been studied for colorectal cancer. Elderly patients in general tend to have comorbidities and decreased organ function that potentially influence the NLR score. The aim of this study was to investigate the relationship betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Tominaga, Tetsuro, Nonaka, Takashi, Oyama, Shosaburo, Takamura, Yuma, Hashimoto, Shintaro, Shiraishi, Toshio, Sawai, Terumitsu, Nagayasu, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830562/
https://www.ncbi.nlm.nih.gov/pubmed/36636228
http://dx.doi.org/10.2147/CEG.S385207
_version_ 1784867695507800064
author Tominaga, Tetsuro
Nonaka, Takashi
Oyama, Shosaburo
Takamura, Yuma
Hashimoto, Shintaro
Shiraishi, Toshio
Sawai, Terumitsu
Nagayasu, Takeshi
author_facet Tominaga, Tetsuro
Nonaka, Takashi
Oyama, Shosaburo
Takamura, Yuma
Hashimoto, Shintaro
Shiraishi, Toshio
Sawai, Terumitsu
Nagayasu, Takeshi
author_sort Tominaga, Tetsuro
collection PubMed
description PURPOSE: The prognostic value of neutrophil-to-lymphocyte ratio (NLR) has been studied for colorectal cancer. Elderly patients in general tend to have comorbidities and decreased organ function that potentially influence the NLR score. The aim of this study was to investigate the relationship between NLR and cancer-specific survival in elderly patients with colon cancer, using a propensity score-matched analysis. PATIENTS AND METHODS: A total of 203 patients aged over 75 years who underwent curative resection for colon cancer and were diagnosed pathologically with stage II/III disease were eligible for entry to the study. Patients were divided into two groups according to NLR score: NLR-High (NLR≥4.5) group (NLR-H, n=60) and NLR-Low (NLR<4.5) group (NLR-L, n=143). After propensity score matching, 57 patients in each group were matched. RESULTS: Before matching, Charlson comorbidity index was significantly higher in the NLR-H group (4 vs 2, p<0.001). After matching, all factors were similar between the groups. The median follow-up period was 43 months (range, 1–160 months). Five-year relapse-free-survival (69.8% vs 87.3%, p=0.030) and cancer-specific survival (83.0% vs 96.0%, p=0.042) were significantly lower in the NLR-H group. CONCLUSION: NLR appears to be a cancer-specific prognostic marker in elderly patients with colon cancer.
format Online
Article
Text
id pubmed-9830562
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-98305622023-01-11 Efficacy of Neutrophil-to-Lymphocyte Ratio for Cancer-Specific Survival in Elderly Patients with Localized Colon Cancer: A Single Center Propensity Score-Matched Analysis Tominaga, Tetsuro Nonaka, Takashi Oyama, Shosaburo Takamura, Yuma Hashimoto, Shintaro Shiraishi, Toshio Sawai, Terumitsu Nagayasu, Takeshi Clin Exp Gastroenterol Original Research PURPOSE: The prognostic value of neutrophil-to-lymphocyte ratio (NLR) has been studied for colorectal cancer. Elderly patients in general tend to have comorbidities and decreased organ function that potentially influence the NLR score. The aim of this study was to investigate the relationship between NLR and cancer-specific survival in elderly patients with colon cancer, using a propensity score-matched analysis. PATIENTS AND METHODS: A total of 203 patients aged over 75 years who underwent curative resection for colon cancer and were diagnosed pathologically with stage II/III disease were eligible for entry to the study. Patients were divided into two groups according to NLR score: NLR-High (NLR≥4.5) group (NLR-H, n=60) and NLR-Low (NLR<4.5) group (NLR-L, n=143). After propensity score matching, 57 patients in each group were matched. RESULTS: Before matching, Charlson comorbidity index was significantly higher in the NLR-H group (4 vs 2, p<0.001). After matching, all factors were similar between the groups. The median follow-up period was 43 months (range, 1–160 months). Five-year relapse-free-survival (69.8% vs 87.3%, p=0.030) and cancer-specific survival (83.0% vs 96.0%, p=0.042) were significantly lower in the NLR-H group. CONCLUSION: NLR appears to be a cancer-specific prognostic marker in elderly patients with colon cancer. Dove 2023-01-05 /pmc/articles/PMC9830562/ /pubmed/36636228 http://dx.doi.org/10.2147/CEG.S385207 Text en © 2023 Tominaga et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Tominaga, Tetsuro
Nonaka, Takashi
Oyama, Shosaburo
Takamura, Yuma
Hashimoto, Shintaro
Shiraishi, Toshio
Sawai, Terumitsu
Nagayasu, Takeshi
Efficacy of Neutrophil-to-Lymphocyte Ratio for Cancer-Specific Survival in Elderly Patients with Localized Colon Cancer: A Single Center Propensity Score-Matched Analysis
title Efficacy of Neutrophil-to-Lymphocyte Ratio for Cancer-Specific Survival in Elderly Patients with Localized Colon Cancer: A Single Center Propensity Score-Matched Analysis
title_full Efficacy of Neutrophil-to-Lymphocyte Ratio for Cancer-Specific Survival in Elderly Patients with Localized Colon Cancer: A Single Center Propensity Score-Matched Analysis
title_fullStr Efficacy of Neutrophil-to-Lymphocyte Ratio for Cancer-Specific Survival in Elderly Patients with Localized Colon Cancer: A Single Center Propensity Score-Matched Analysis
title_full_unstemmed Efficacy of Neutrophil-to-Lymphocyte Ratio for Cancer-Specific Survival in Elderly Patients with Localized Colon Cancer: A Single Center Propensity Score-Matched Analysis
title_short Efficacy of Neutrophil-to-Lymphocyte Ratio for Cancer-Specific Survival in Elderly Patients with Localized Colon Cancer: A Single Center Propensity Score-Matched Analysis
title_sort efficacy of neutrophil-to-lymphocyte ratio for cancer-specific survival in elderly patients with localized colon cancer: a single center propensity score-matched analysis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9830562/
https://www.ncbi.nlm.nih.gov/pubmed/36636228
http://dx.doi.org/10.2147/CEG.S385207
work_keys_str_mv AT tominagatetsuro efficacyofneutrophiltolymphocyteratioforcancerspecificsurvivalinelderlypatientswithlocalizedcoloncancerasinglecenterpropensityscorematchedanalysis
AT nonakatakashi efficacyofneutrophiltolymphocyteratioforcancerspecificsurvivalinelderlypatientswithlocalizedcoloncancerasinglecenterpropensityscorematchedanalysis
AT oyamashosaburo efficacyofneutrophiltolymphocyteratioforcancerspecificsurvivalinelderlypatientswithlocalizedcoloncancerasinglecenterpropensityscorematchedanalysis
AT takamurayuma efficacyofneutrophiltolymphocyteratioforcancerspecificsurvivalinelderlypatientswithlocalizedcoloncancerasinglecenterpropensityscorematchedanalysis
AT hashimotoshintaro efficacyofneutrophiltolymphocyteratioforcancerspecificsurvivalinelderlypatientswithlocalizedcoloncancerasinglecenterpropensityscorematchedanalysis
AT shiraishitoshio efficacyofneutrophiltolymphocyteratioforcancerspecificsurvivalinelderlypatientswithlocalizedcoloncancerasinglecenterpropensityscorematchedanalysis
AT sawaiterumitsu efficacyofneutrophiltolymphocyteratioforcancerspecificsurvivalinelderlypatientswithlocalizedcoloncancerasinglecenterpropensityscorematchedanalysis
AT nagayasutakeshi efficacyofneutrophiltolymphocyteratioforcancerspecificsurvivalinelderlypatientswithlocalizedcoloncancerasinglecenterpropensityscorematchedanalysis